NetraMark Holdings Inc. (AINMF)
OTCMKTS · Delayed Price · Currency is USD
0.7260
-0.0284 (-3.76%)
Feb 12, 2026, 12:01 PM EST
NetraMark Holdings Revenue
NetraMark Holdings had revenue of 118.85K CAD in the quarter ending December 31, 2025, a decrease of -69.22%. This brings the company's revenue in the last twelve months to 165.26K, down -80.37% year-over-year. In the fiscal year ending September 30, 2025, NetraMark Holdings had annual revenue of 432.50K, down -5.18%.
Revenue (ttm)
165.26K CAD
Revenue Growth
-80.37%
P/S Ratio
525.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
63.31M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 432.50K | -23.63K | -5.18% |
| Sep 30, 2024 | 456.13K | 366.86K | 410.97% |
| Sep 30, 2023 | 89.27K | -23.76K | -21.02% |
| Sep 30, 2022 | 113.03K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |
NetraMark Holdings News
- 14 days ago - NetraMark Strengthens Board Of Directors - GlobeNewsWire
- 15 days ago - NetraMark Closes First Tranche of Private Placement - GlobeNewsWire
- 21 days ago - NetraMark Engages LodeRock Advisors for Strategic Investor Relations and Capital Markets Communications Services - GlobeNewsWire
- 4 weeks ago - NetraMark Announces Private Placement Financing - GlobeNewsWire
- 2 months ago - NetraMark Delivers Transformational Quarter Of Execution - GlobeNewsWire
- 2 months ago - NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression - GlobeNewsWire
- 2 months ago - NetraMark Achieves Major FDA Milestone - GlobeNewsWire
- 2 months ago - NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company - GlobeNewsWire